Brain

1. GIOVANNONI G, James L, Adeniran AA, Gold J, et al
   The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis.
   Brain. 2025 May 6:awaf170. doi: 10.1093.
   

   >> Share

   
   

   
   J Neuroimmunol

2. PETROU P, Kassis I, Levi Y, Yaghmour N, et al
   Kinetics of serum NFL and GFAP and changes in cognitive functions, in MS patients treated with repeated administrations of autologous mesenchymal stem cells (MSC-NG01).
   J Neuroimmunol. 2025;403:578613.
   

   >> Share

   
   

   
   J Neurol

3. FREEDMAN DE, Oh J, Einstein G, Feinstein A, et al
   Aging and the neuropsychiatry of multiple sclerosis: a cross-sectional study.
   J Neurol. 2025;272:375.
   

   >> Share

   
   
4. KOLB H, Shachaf Y, Fainberg K, Golan M, et al
   Intrathecal methotrexate in progressive multiple sclerosis: a phase 1 open-label study with long-term follow-up.
   J Neurol. 2025;272:374.
   

   >> Share

   
   
5. HERMAN D, Tanniou J, Leray E, Pierret C, et al
   Analyzing recurrent events in multiple sclerosis: a review of statistical models with application to the MSOAC database.
   J Neurol. 2025;272:371.
   

   >> Share

   
   

   
   Mayo Clin Proc

6. KWON S, Han KD, Jung JH, Cho EB, et al
   Risk of Autoimmune Rheumatic Diseases in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Nationwide Cohort Study in South Korea.
   Mayo Clin Proc. 2025;100:801-813.
   

   >> Share

   
   
7. TORKILDSEN O
   Multiple Sclerosis, NMOSD, and the Risk of Autoimmune Diseases.
   Mayo Clin Proc. 2025;100:773-775.
   

   >> Share

   
   

   
   Mult Scler

8. MACCARRONE D, Prados F, Ciccarelli O
   The relationship between cladribine and reduced regional grey matter volume loss in people with relapsing-remitting multiple sclerosis.
   Mult Scler. 2025 May 3:13524585251338772. doi: 10.1177/13524585251338772.
   

   >> Share

   
   
9. LOREFICE L, Zivadinov R
   Treating comorbidities in multiple sclerosis is disease-modifying: Yes.
   Mult Scler. 2025 May 3:13524585251338750. doi: 10.1177/13524585251338750.
   

   >> Share

   
   

   
   PLoS Biol

10. HILL BM, Holloway RK, Forbes LH, Davies CL, et al
    Monocyte-secreted Wnt reduces the efficiency of central nervous system remyelination.
    PLoS Biol. 2025;23:e3003073.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share